Research Progress of Neuroprotective Mechanism of Caffeine on Parkinson's Disease in Recent Ten Years

References:

[1]Sarkar S,Nguyen HM,Malovic E,et al.Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson & apos's disease[J].The Journal of Clinical Investigation,2020,130(8):4195-4212.
[2]Ikram M,Park TJ,Ali T,et al.Antioxidant and neuroprotective effects of caffeine against Alzheimer & apos's and Parkinson & apos's disease:insight into the role of nrf-2 and A2AR signaling[J].Antioxidants,2020,9(9):902.
[3]Poewe W.Parkinson disease Primer-a true team effort[J].Nat Rev Dis Primers,2020 Apr 23,6(1):31.
[4]Chen SQ,Wang ZS,Ma YX,et al.Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases[J].Molecules (Basel,Switzerland),2018,23(3):512.
[5]Devasagayam TPA,Kamat JP,Mohan HR,et al.Caffeine as an antioxidant:inhibition of lipid peroxidation induced by reactive oxygen species[J].Biochimica Biophysica Acta (BBA)-Biomembranes,1996,1282(1):63-70.
[6]Ullah F,Ali T,Ullah N,et al.Caffeine prevents d-galactose-induced cognitive deficits,oxidative stress,neuroinflammation and neurodegeneration in the adult rat brain[J].Neurochemistry International,2015,90:114-124.
[7]Shi X,Dalal NS,Jain AC.Antioxidant behaviour of caffeine:efficient scavenging of hydroxyl radicals[J].Food and Chemical Toxicology,1991,29(1):1-6.
[8]Chavez-Valdez R,Wills-Karp M,Ahlawat R,et al.Caffeine modulates TNF-alpha production by cord blood monocytes:the role of adenosine receptors[J].Pediatric Research,2009,65(2):203-208.
[9]Ikram M,Saeed K,Khan A,et al.Natural dietary supplementation of curcumin protects mice brains against ethanol-induced oxidative stress-mediated neurodegeneration and memory impairment via Nrf2/TLR4/RAGE signaling[J].Nutrients,2019,11(5):1082.
[10]Vingill S,Connor-Robson N,Wade-Martins R.Are rodent models of Parkinson & apos's disease behaving as they should[J].Behavioural Brain Research,2018,352:133-141.
[11]Hayashi A,Matsunaga N,Okazaki H,et al.A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson & apos's disease[J].NeuroMolecular Medicine,2013,15(2):238-251.
[12]Xu K,Xu YH,Brown-Jermyn D,et al.Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson & apos's disease[J].The Journal of Neuroscience:the Official Journal of the Society for Neuroscience,2006,26(2):535-541.
[13]Bagga P,Chugani AN,Patel AB.Neuroprotective effects of caffeine in MPTP model of Parkinson & apos's disease:a 13C NMR study[J].Neurochemistry International,2016,92:25-34.
[14]Sonsalla PK,Wong LY,Harris SL,et al.Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson & apos's [J].Experimental Neurology,2012,234(2):482-487.
[15]Sacino AN,Brooks M,McKinney AB,et al.Brain injection of α-synuclein induces multiple proteinopathies,gliosis,and a neuronal injury marker[J].The Journal of Neuroscience:the Official Journal of the Society for Neuroscience,2014,34(37):12368-12378.
[16]Madeira MH,Boia R,Ambrósio AF,et al.Having a coffee break:the impact of caffeine consumption on microglia-mediated inflammation in neurodegenerative diseases [J].Mediators of Inflammation,2017,2017:4761081.
[17]Xu K,Xu YH,Chen JF,et al.Caffeine & apos's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice[J].Neuroscience Letters,2002,322(1):13-16.
[18]Chen XS,Lan X,Roche I,et al.Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum[J].Journal of Neurochemistry,2008,107(4):1147-1157.
[19]Ren XP,Chen JF.Caffeine and Parkinson & apos's disease:multiple benefits and emerging mechanisms[J].Frontiers in Neuroscience,2020,14:602697.
[20]Ferreira DG,Batalha VL,Vicente Miranda H,et al.Adenosine A2A receptors modulate α-synuclein aggregation and toxicity[J].Cerebral Cortex,2015,27(1):718-730.
[21]Ferreira DG,Temido-Ferreira M,Vicente Miranda H,et al.α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B[J].Nat Neurosci,2017 Nov,20(11):1569-1579.
[22]Ferré S,Díaz-Ríos M,Salamone JD,et al.New developments on the adenosine mechanisms of the central effects of caffeine and their implications for neuropsychiatric disorders[J].Journal of Caffeine and Adenosine Research,2018,8(4):121-131.
[23]Schmidt WJ,Alam M.Controversies on new animal models of Parkinson & apos's disease pro and con:the rotenone model of Parkinson & apos's disease (PD) [J].Journal of Neural Transmission Supplementum,2006,(70):273-276.
[24]Khadrawy YA,Salem AM,El-Shamy KA,et al.Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson & apos's disease induced by rotenone[J].Journal of Dietary Supplements,2017,14(5):553-572.
[25]Miyazaki I,Asanuma M,Hozumi H,et al.Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity[J].FEBS Letters,2007,581(25):5003-5008.
[26]Miyazaki I,Isooka N,Wada K,et al.Effects of enteric environmental modification by coffee components on neurodegeneration in rotenone-treated mice[J].Cells,2019,8(3):221.
[27]Silva RB,Santos NAG,Martins NM,et al.Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats [J].Neuroscience,2013,233:86-94.
[28]Shen WJ,Qi RB,Zhang J,et al.Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons[J].Brain Research Bulletin,2012,88(5):487-494.
[29]Machado-Filho JA,Correia AO,Montenegro ABA,et al.Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors,including pro-inflammatory cytokines and histone deacetylase inhibitions[J].Behavioural Brain Research,2014,264:116-125.
[30]杨谦谦.6-OHDA诱导帕金森病大鼠模型行为学评价方法的探讨及龙胆苦苷对该模型神经保护作用的研究[D].张家口:河北北方学院，2014.
[31]Xu K,di Luca DG,Orrú M,et al.Neuroprotection by caffeine in the MPTP model of Parkinson & apos's disease and its dependence on adenosine A2A receptors [J].Neuroscience,2016,322:129-137.
[32]Kalia LV,Kalia SK.Α-Synuclein and Lewy pathology in Parkinson & apos's disease[J].Current Opinion in Neurology,2015,28(4):375-381.
[33]Luan YN,Ren XP,Zheng W,et al.Chronic caffeine treatment protects against α-synucleinopathy by reestablishing autophagy activity in the mouse striatum [J].Frontiers in Neuroscience,2018,12:301.
[34]Cerri S,Blandini F.Role of autophagy in Parkinson & apos's disease[J].Current Medicinal Chemistry,2019,26(20):3702-3718.
[35]Lamonaca G,Volta M.Alpha-synuclein and LRRK2 in synaptic autophagy:linking early dysfunction to late-stage pathology in Parkinson & apos's disease [J].Cells,2020,9(5):1115.
[36]Wan SX，Pan X，Qian JJ，et al.Downregulation of ATP13A2 in midbrain dopaminergic neurons is related to defective autophagy in a mouse model of Parkinson's disease[J].Int J Clin Exp Pathol,2020 Jul 1,13(7):1853-1858.
[37]Webb JL,Ravikumar B,Atkins J,et al.Alpha-synuclein is degraded by both autophagy and the proteasome[J].The Journal of Biological Chemistry,2003,278(27):25009-25013.
[38]Guo YL,Duan WJ,Lu DH,et al.Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease[J].Acta Pharmacol Sin,2021 Apr,42(4):518-528.
[39]Corti O,Blomgren K,Poletti A,et al.Autophagy in neurodegeneration:new insights underpinning therapy for neurological diseases[J].Journal of Neurochemistry,2020,154(4):354-371.